Reidenberg M. Response to "The Need for Clinical Pharmacology Is Greater Than Ever" Clin Pharmacol Ther. 2008 Apr 16. [Epub ahead of print]
PMID: 18418371

Reidenberg MM. A new look at the profession of clinical pharmacology. Clin Pharmacol Ther. 2008 Feb;83(2):213-7.
PMID: 18202686

Reidenberg MM. Essential medicines for the whole world. Clin Pharmacol Ther. 2007 Nov;82(5):500-3.
PMID: 17952105

Jung B, Reidenberg MM. Physicians being deceived. Pain Med. 2007 Jul-Aug;8(5):433-7.
PMID: 17661857

Reidenberg MM. Benefit/risk ratio of statins in primary prevention. Clin Pharmacol Ther. 2008 Mar;83(3):498-500. Epub 2007 May 30. Review.
PMID: 17538549

Reidenberg MM. Statins for primary prevention of coronary artery disease. Lancet. 2007 Mar 31;369(9567):1078; author reply 1079.
PMID: 17398297

Reidenberg MM, Willis O. Prosecution of physicians for prescribing opioids to patients. Clin Pharmacol Ther. 2007 Jun;81(6):903-6. Epub 2007 Feb 28.
PMID: 17329989

Reidenberg MM. World Health Organization program for the selection and use of essential medicines. Clin Pharmacol Ther. 2007 Apr;81(4):603-6. Epub 2007 Feb 21.
PMID: 17314928

Reidenberg MM. Are drugs for rare diseases "essential"? Bull World Health Organ. 2006 Sep;84(9):686.
PMID: 17128329

Jung B, Reidenberg MM. The risk of action by the Drug Enforcement Administration against physicians prescribing opioids for pain. Pain Med. 2006 Jul-Aug;7(4):353-7.
PMID: 16898947

Reidenberg MM. Improving how we evaluate the toxicity of approved drugs. Clin Pharmacol. 2006; 80: 1-6.

Reidenberg MM. Clinical trials report card. N Engl J Med. 354:1428, 2006. Letter.

Reidenberg MM. We should not say "drug safety" when we mean drug toxicity". WHO Pharmaceuticals Newsletter. No. 2, 7-8, 2006.

Reidenberg MM. Informed consent or acknowledgment of disclosure. Clin Pharmacol Ther. Oct;78(4):439-40, 2005.

Reidenberg MM. Pay for performance. ACP Observer. Jan-Feb:3, 2005. Letter.

Jung BF, Reidenberg MM. Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Ther. 77(4):324-34, 2005. Review.

Reidenberg MM. Statins, lack of energy and ubiquinone. British Journal Clinical Pharmacology. 59(5):606-7, 2005.

Richard J, Reidenberg MM. The risk of disciplinary action by state medical boards against physicians prescribing opioids. J Pain Symptom Manage. 29(2):206-12, 2005.

Reidenberg MM. Issues in developing the medical scientist, Part 3: Evaluation of scientific achievement (essay by and interview with Marcus M. Reidenberg, MD). J Investig Med. 52(6):361-3, 2004. Review.

Reidenberg MM, Walley T. The pros and cons of essential medicines for rich countries. BMJ. 329(7475):1172, 2004.

Demayo AP, Reidenberg MM. Grand mal seizure in a child 30 minutes after Cyclogyl (cyclopentolate hydrochloride) and 10% Neo-Synephrine (phenylephrine hydrochloride) eye drops were instilled. Pediatrics. 113(5):e499-500, 2004.

Reidenberg MM, Willis O. Prosecutions of physicians for prescribing opioids. Clin Pharmacol Ther. 2007; 81: 903-906.

Reidenberg MM. World Health Organization program for the selection and use of essential medicines. Clin Pharmacol Ther 2007; 81: 603-6.

Other Publications